What Cannabis Operators Actually Need Before a Lender Will Listen

Between us we have built a licensed cannabis business from the ground up, run the operations inside one, and sat on the regulator's side of the table while this industry's banking rules were written. We come at this from three directions and land in the same place. The operators who make it through this period will not be the ones with the best flower. They will be the ones who can prove how they run.

Capital access in cannabis gets discussed as a policy problem waiting on Washington. Some of it is. But much of what stands between an operator and affordable money is internal, and fixable now, without permission from anyone.

Here is what that actually takes.

Uncertainty Is Now the Permanent Condition

Anyone who enters cannabis has to accept how hard it is to predict what happens next, and that uncertainty is itself a source of pressure. Rescheduling is underway. By order, a state-licensed medical operator now sits in Schedule 3 and is no longer subject to 280E on its face. That does not extend to the recreational side, and nobody knows if it will.

Meanwhile operators sign contracts, build a chart of accounts, and model against an answer that does not exist yet. Most know the term 280E and expect compliance costs. Where it breaks down is the modeling, which often does not account for 280E correctly. Add an infused hemp market competing from a largely unregulated position and the pressure compounds. We are not making predictions. We have been wrong before.

Legal Authority and Financial Readiness Are Different Pictures

Policies do not execute themselves. Readiness takes people, systems, and controls with escalation paths that reach a named decision maker, long before financing enters the conversation. What an underwriter buys is predictability and stability held over time, including over the hurdles and the things that did not go right.

“The legal authority is one thing. Financial readiness is a different picture. It is not whether you opened yesterday. It is how long you have been operating in a way an outside party can see, and whether that is written down and durable rather than word of mouth.”

Most institutions want three years of financials, audited where possible. When the April order moved medical operators out of 280E, we expected banks to move faster than they have. They have not, because the constraint was never only the tax code. It is the absence of a record that can be read.

In an Asset-Light Industry, the Books Are the Collateral

The asset-light model took hold largely because 280E denies deductions for depreciation and similar items, which constrains what an operator can justify owning. That choice makes sense on the tax side and arrives at the bank as a problem. Where there are no hard assets, the books are the only thing left to underwrite.

“If you do not have the books, the accounting, and the history in systems, there is no asset and no other collateral. You hit a roadblock. Without that informational infrastructure, reaching the financing that is starting to open up is close to impossible.”

Where the State Can Move, and Has Not Yet

There is a mechanism sitting unused. New York's cannabis law and finance law, read together, allow a fund financed out of cannabis taxes and license proceeds, with authority broad enough to lend at no interest. A footnote in the state's social and economic equity plan raised the concept of a loan loss reserve, and it deserves to be built.

It matters most for social equity applicants, who are often required to keep a certain level of equity and control and therefore cannot solve the problem with outside capital. A reserve that protects a lender's principal turns a borrower the bank would decline into one it can approve. New York already applies this structure elsewhere, and the earlier attempt at direct state financing failed on administration, not concept. From an underwriting seat, that is real comfort.

Margin Discipline Is the Differentiation

Grow it and they will come is not a strategy. Massachusetts is posting near-record sales, roughly $1.65 billion, alongside falling retail prices, and that compression is not solved by growing more or selling more. It is solved by another lever inside the operation. Retail is finicky, seasonal, and different down to the zip code, and shelf space is prime in all of them.

The levers are margin discipline and inventory management. Cash tied up in inventory while vendors wait creates friction and transaction cost that lands straight in the P&L, and a reputation for paying on time is worth more than most operators think. An ERP that ties inventory, cost accounting, and reporting together tells you which products to lean into and which to retire. At manufacturing scale this is closer to consumer packaged goods than many will admit: high volume, thin margins. Without visibility into them you are flying blind. AI does not replace that judgment. It scales it, and brings its cost down to the operator's level.

Compliance Is Cheaper at the Front End

In cannabis, compliance is everyone's job. The documentation side, whether GMP or state regulation, gets treated as secondary to operational culture, and that mismatch is where cost accumulates. Current SOPs, real training, and records that match how work actually happens are an upfront investment, hard to make when the alternative is ship now and worry later. Non-compliance always costs more.

“I have always been a fan of carrots for compliance. When a financial institution decides to start lending, the first people it offers financing to are the ones who were transparent, forthcoming, and on time with everything compliance asked them for.”

The workforce side is the same. Cross-trained pods with named roles let an operator expand or contract without hiring and firing, and a continuity plan reads to an underwriter as clearly as the numbers. Be your own worst critic and catch the gap before the examiner does, because examiners want to see that you caught it first. It is expensive to be reactive.

The Bottom Line

No one is handing this industry a clean federal answer soon. The 2014 FinCEN guidance is still the bedrock twelve years on, federal treatment of THC remains a mess, and the recent movement has made some institutions more cautious rather than less.

What is available now is the part operators control: tight books, clean inventory, decisions that leave a record. Build the evidence before you need the money.